Multiple Reaction Monitoring-Based Targeted Assays for the Validation of Protein Biomarkers in Brain Tumors

The emergence of omics technologies over the last decade has helped in advancement of research and our understanding of complex diseases like brain cancers. However, barring genomics, no other omics technology has been able to find utility in clinical settings. The recent advancements in mass spectr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghantasala, Saicharan, Pai, Medha Gayathri J., Biswas, Deeptarup, Gahoi, Nikita, Mukherjee, Shuvolina, KP, Manubhai, Nissa, Mehar Un, Srivastava, Alisha, Epari, Sridhar, Shetty, Prakash, Moiyadi, Aliasgar, Srivastava, Sanjeeva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8162214/
https://www.ncbi.nlm.nih.gov/pubmed/34055594
http://dx.doi.org/10.3389/fonc.2021.548243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8162214/
https://www.ncbi.nlm.nih.gov/pubmed/34055594
http://dx.doi.org/10.3389/fonc.2021.548243

Ejemplares similares